Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-24 @ 4:36 PM
NCT ID:
NCT00452166
Eligibility Criteria:
Inclusion Criteria:
* CKD stage 4
* BMI ≤ 30
* Fasting glucose \< 7 mmol/l
Exclusion Criteria:
Exclusion of patients will take place in case of:
* A diagnosis of diabetes mellitus for which the patient uses insulin
* Significant co-morbidities which, according to the treating nephrologists, makes it unlikely that the patient will be able to complete the foreseen study period
* Significant cardiovascular co-morbidities which are likely to interfere with the objectives of the study (morbid obesity, family history of dyslipidemia, etc.); at the discretion of the treating nephrologists or the principal investigator
* Allergy for PPAR's
* Cardiac disease with marked limitation of functional capacity (New York Heart Association III or IV clinical status)
* Use of immunosuppressant agents
* History of renal transplant
* Hepatic insufficiency (defined as transaminase concentrations above \> 2.5 times the upper limit of normal for the laboratories)
* A history of alcohol abuse or excessive alcohol use defined as more than 21 consumptions per week
* For female patients: pregnancy, the intention to become pregnant within the study period, or lactating patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00452166
Study Brief:
Protocol Section:
NCT00452166